BioSpace News Archive

Business

PROMETHERA Biosciences S.A./N.V. Reshapes Its Leadership Team

January 23, 2015
·
2 min read
Drug Development

Gem Pharmaceuticals Announces Enrollment Of Initial Patients In Its Phase 2 Clinical Trial To Assess The Efficacy And Safety Of GPX-150 In Sarcoma Patients

January 23, 2015
·
3 min read
Business

Amgen Announces Webcast Of 2014 Fourth Quarter And Full Year Financial Results

January 23, 2015
·
2 min read
Pharm Country

Merck & Co., On Behalf Of Its Wholly Owned Subsidiary, Cubist Pharmaceuticals, Inc., Announces Tender Offer For Cubist’s 2.50% Convertible Senior Notes Due 2017, 1.125% Convertible Senior Notes Due 2018 And 1.875% Convertible Senior Notes Due 2020

January 23, 2015
·
1 min read
BioMidwest

Peak Pharmaceuticals Develops Market Entry Strategy And Plan Aided By Outstanding Executive MBA Teams

January 23, 2015
·
4 min read
Pivotal Therapeutics Inc.: Year In Review And CEO Update

January 23, 2015
·
10 min read
Axxess Pharma, Inc. Returns From National ECRM Event With Scheduled Follow-Up Meetings With Big Box Retail Chain Stores And Specialty Stores

January 23, 2015
·
4 min read
BioCapital

Northwest Biotherapeutics To Present At The 7th Annual Phacilitate Immunotherapy Forum

January 23, 2015
·
3 min read
Business

Tiziana Life Sciences Plc: Board Changes

January 23, 2015
·
4 min read
Drug Development

Regeneron Release: EYLEA® (aflibercept) Injection Recommended For Approval For The Treatment Of Visual Impairment Due To Macular Edema Secondary To Central Or Branch Retinal Vein Occlusion In The European Union

January 23, 2015
·
8 min read